vs
Side-by-side financial comparison of American Healthcare REIT, Inc. (AHR) and IDEX Corporation (IEX). Click either name above to swap in a different company.
IDEX Corporation is the larger business by last-quarter revenue ($899.1M vs $564.0M, roughly 1.6× American Healthcare REIT, Inc.). IDEX Corporation runs the higher net margin — 14.3% vs 1.9%, a 12.4% gap on every dollar of revenue. On growth, IDEX Corporation posted the faster year-over-year revenue change (376.5% vs 13.5%). Over the past eight quarters, American Healthcare REIT, Inc.'s revenue compounded faster (11.7% CAGR vs 5.5%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
IDEX can refer to several things, including:International Defence Exhibition, a biennial arms and defense technology sales exhibition IDEX Corporation, a publicly listed company that makes fluidics systems and specialty engineered products Ideanomics, a publicly traded company that trades under the IDEX ticker symbol.
AHR vs IEX — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $564.0M | $899.1M |
| Net Profit | $10.8M | $128.3M |
| Gross Margin | 14.8% | 43.1% |
| Operating Margin | 19.8% | 20.4% |
| Net Margin | 1.9% | 14.3% |
| Revenue YoY | 13.5% | 376.5% |
| Net Profit YoY | 133.9% | 688.5% |
| EPS (diluted) | $0.07 | $1.71 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $899.1M | ||
| Q4 25 | $564.0M | $899.1M | ||
| Q3 25 | $532.1M | $878.7M | ||
| Q2 25 | $501.3M | $865.4M | ||
| Q1 25 | $497.2M | $814.3M | ||
| Q4 24 | $496.8M | $862.9M | ||
| Q3 24 | $476.8M | $798.2M | ||
| Q2 24 | $458.0M | $807.2M |
| Q1 26 | — | $128.3M | ||
| Q4 25 | $10.8M | $128.3M | ||
| Q3 25 | $55.9M | $127.8M | ||
| Q2 25 | $9.9M | $131.6M | ||
| Q1 25 | $-6.8M | $95.5M | ||
| Q4 24 | $-31.8M | $123.2M | ||
| Q3 24 | $-4.1M | $119.1M | ||
| Q2 24 | $2.0M | $141.3M |
| Q1 26 | — | 43.1% | ||
| Q4 25 | 14.8% | 43.1% | ||
| Q3 25 | 14.6% | 44.5% | ||
| Q2 25 | 15.0% | 45.3% | ||
| Q1 25 | 13.0% | 45.3% | ||
| Q4 24 | 13.3% | 42.5% | ||
| Q3 24 | 12.5% | 44.3% | ||
| Q2 24 | 12.1% | 45.4% |
| Q1 26 | — | 20.4% | ||
| Q4 25 | 19.8% | 20.4% | ||
| Q3 25 | 19.9% | 21.1% | ||
| Q2 25 | 20.6% | 21.7% | ||
| Q1 25 | 19.0% | 17.4% | ||
| Q4 24 | 20.0% | 19.2% | ||
| Q3 24 | 19.6% | 21.0% | ||
| Q2 24 | 19.4% | 22.6% |
| Q1 26 | — | 14.3% | ||
| Q4 25 | 1.9% | 14.3% | ||
| Q3 25 | 10.5% | 14.5% | ||
| Q2 25 | 2.0% | 15.2% | ||
| Q1 25 | -1.4% | 11.7% | ||
| Q4 24 | -6.4% | 14.3% | ||
| Q3 24 | -0.9% | 14.9% | ||
| Q2 24 | 0.4% | 17.5% |
| Q1 26 | — | $1.71 | ||
| Q4 25 | $0.07 | $1.71 | ||
| Q3 25 | $0.33 | $1.70 | ||
| Q2 25 | $0.06 | $1.74 | ||
| Q1 25 | $-0.04 | $1.26 | ||
| Q4 24 | $-0.23 | $1.61 | ||
| Q3 24 | $-0.03 | $1.57 | ||
| Q2 24 | $0.01 | $1.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $114.8M | $580.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.3B | $4.0B |
| Total Assets | $5.4B | $6.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $580.0M | ||
| Q4 25 | $114.8M | $580.0M | ||
| Q3 25 | $147.4M | $593.8M | ||
| Q2 25 | $133.5M | $568.2M | ||
| Q1 25 | $86.1M | $594.1M | ||
| Q4 24 | $76.7M | $620.8M | ||
| Q3 24 | $67.8M | $633.2M | ||
| Q2 24 | $52.1M | $700.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | $1.9B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | — | $1.3B |
| Q1 26 | — | $4.0B | ||
| Q4 25 | $3.3B | $4.0B | ||
| Q3 25 | $2.7B | $4.0B | ||
| Q2 25 | $2.4B | $4.0B | ||
| Q1 25 | $2.3B | $3.9B | ||
| Q4 24 | $2.3B | $3.8B | ||
| Q3 24 | $2.2B | $3.8B | ||
| Q2 24 | $1.9B | $3.7B |
| Q1 26 | — | $6.9B | ||
| Q4 25 | $5.4B | $6.9B | ||
| Q3 25 | $4.8B | $7.0B | ||
| Q2 25 | $4.5B | $6.9B | ||
| Q1 25 | $4.5B | $6.8B | ||
| Q4 24 | $4.5B | $6.7B | ||
| Q3 24 | $4.7B | $7.0B | ||
| Q2 24 | $4.6B | $5.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.45× | ||
| Q3 25 | — | 0.48× | ||
| Q2 25 | — | 0.46× | ||
| Q1 25 | — | 0.50× | ||
| Q4 24 | — | 0.52× | ||
| Q3 24 | — | 0.55× | ||
| Q2 24 | — | 0.36× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $55.2M | — |
| Free Cash FlowOCF − Capex | — | $189.8M |
| FCF MarginFCF / Revenue | — | 21.1% |
| Capex IntensityCapex / Revenue | — | 7.1% |
| Cash ConversionOCF / Net Profit | 5.12× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $715.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $55.2M | $209.5M | ||
| Q3 25 | $107.2M | $203.5M | ||
| Q2 25 | $71.5M | $161.7M | ||
| Q1 25 | $60.6M | $105.7M | ||
| Q4 24 | $59.5M | $172.6M | ||
| Q3 24 | $63.1M | $205.3M | ||
| Q2 24 | $59.4M | $133.6M |
| Q1 26 | — | $189.8M | ||
| Q4 25 | — | $189.8M | ||
| Q3 25 | — | $188.7M | ||
| Q2 25 | — | $146.9M | ||
| Q1 25 | — | $91.4M | ||
| Q4 24 | — | $157.1M | ||
| Q3 24 | — | $191.6M | ||
| Q2 24 | — | $117.7M |
| Q1 26 | — | 21.1% | ||
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 21.5% | ||
| Q2 25 | — | 17.0% | ||
| Q1 25 | — | 11.2% | ||
| Q4 24 | — | 18.2% | ||
| Q3 24 | — | 24.0% | ||
| Q2 24 | — | 14.6% |
| Q1 26 | — | 7.1% | ||
| Q4 25 | — | 2.2% | ||
| Q3 25 | — | 1.7% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 1.8% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 5.12× | 1.63× | ||
| Q3 25 | 1.92× | 1.59× | ||
| Q2 25 | 7.21× | 1.23× | ||
| Q1 25 | — | 1.11× | ||
| Q4 24 | — | 1.40× | ||
| Q3 24 | — | 1.72× | ||
| Q2 24 | 30.02× | 0.95× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AHR
| Integrated Senior Health Campuses | $467.0M | 83% |
| SHOP | $97.0M | 17% |
IEX
Segment breakdown not available.